Regenerative Care for Erectile Dysfunction Treatments

Integrative Chiropractic and Functional Medicine Strategies for Erectile Dysfunction: Evidence-Based, Regenerative, and Multidisciplinary Care in Men’s Health

Abstract

In this educational post, I guide you through a comprehensive, first-person overview of erectile dysfunction (ED) as I approach it in clinical practice at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas. This post outlines a practical, evidence-based pathway that starts with recognizing ED as a multidimensional condition and a potential sentinel marker of cardiometabolic disease. It is explained how I integrate chiropractic care with internal medicine oversight from our Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), within a multidisciplinary care model that includes functional medicine, personal injury care, rehabilitation, regenerative medicine, and men’s health-focused lifestyle programs.

We walk through the physiology of erection, nitric oxide biology, vascular and neurogenic mechanisms, hormonal axes, psychogenic factors, and iatrogenic contributors. I also present evidence for PDE5 inhibitors, extracorporeal shockwave therapy, and platelet-rich plasma (PRP), and clarify when and how we layer peptide therapies and testosterone optimization, including rigorous safety monitoring. Throughout, I describe how our integrative chiropractic methods—spinal and pelvic alignment, neuromyofascial release, autonomic balancing, and movement rehabilitation—fit into ED care by improving perfusion, reducing pain and sympathetic overdrive, and restoring functional capacity. I include practical screening tools, stepwise algorithms, contraindications, follow-up planning, and patient communication strategies, and I highlight published research to support clinical decisions. This post is designed to be clear, actionable, and clinically detailed, emphasizing why each technique is used and how it fits into individualized, patient-centered care.

Introduction: Why Men’s Health and Erectile Dysfunction Matter in an Integrative Clinic

I value honest, direct conversations about men’s health. When a man tells me, “Doc, I have ED—what can you do besides the blue pill?”, I hear an opportunity to protect his heart, brain, metabolic health, and quality of life. ED is common and increases with age. It involves multiple systems—vascular, neurological, hormonal, and psychological—and it frequently signals underlying cardiometabolic risk. In our clinic, I see ED as more than a symptom of sexual dysfunction: it can be an early window into systemic health.

At Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic), we built a team to meet that challenge. I am Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. Our Medical Director, Dr. Maria Guadalupe Cardenas, MD (Internal Medicine), brings over 40 years of experience managing complex medical issues. Dr. Cardenas provides medical oversight and collaborative guidance for pharmacologic therapy, diagnostics, and risk stratification, while I lead integrative chiropractic and functional medicine interventions. Together, we coordinate care that addresses the root causes of ED—cardiovascular health, endocrine balance, neurovascular integrity, pain and mobility, stress physiology, and lifestyle.

In this post, I present contemporary evidence for conventional and regenerative therapies—PDE5 inhibitors, extracorporeal shockwave therapy, PRP—and I explain when testosterone and peptide therapies can be appropriate, and why screening for cardiovascular disease is non-negotiable. I also show how chiropractic and rehab fit into a men’s health strategy that improves pelvic blood flow, neuromuscular control, and autonomic balance. My goal is to give you a clear roadmap—from first visit through long-term follow-up—rooted in modern research and real-world clinical experience.

What You Will Learn

• Why erectile dysfunction is a cardiometabolic warning sign and how we screen accordingly
• How vascular, neurogenic, hormonal, psychogenic, drug-induced, and iatrogenic factors converge to cause ED
• Where PDE5 inhibitors fit—and why tachyphylaxis happens
• How extracorporeal shockwave therapy and PRP support vascular remodeling and nerve repair
• When to consider testosterone and how to do it safely with internal medicine oversight
• Which peptides may complement ED care and what side effects to anticipate
• How integrative chiropractic care supports pelvic perfusion, autonomic balance, pain reduction, and functional recovery
• How to build a stepwise, personalized, and multidisciplinary plan with outcome tracking and safety monitoring

Section 1: Understanding Erectile Dysfunction as a Whole-Body Signal

Key points I emphasize with every patient:

• ED is commonly the first visible sign of systemic vascular disease.
• ED prevalence rises with age; comorbidities and medications often contribute.
• ED is defined as the consistent inability to attain or maintain an erection sufficient for satisfactory sexual performance, with an impact on quality of life and relationships.
• Because penile arteries are small-caliber vessels, they may show vascular compromise earlier than coronary or carotid arteries, making ED a potential early marker of endothelial dysfunction and atherosclerosis.

Why this matters clinically

• Many men are reluctant to discuss sexual symptoms. When they do, we must use that moment well.
• Cardiovascular risk stratification and metabolic screening can prevent adverse events and guide therapy choices.
• A one-dimensional approach misses key drivers: blood flow, nerve integrity, hormonal milieu, medication side effects, and stress physiology.

The collaborative model

• In our clinic, Dr. Cardenas oversees medical evaluation. I integrate musculoskeletal, neurologic, and functional tactics to improve pelvic circulation and reduce pain, stress, and deconditioning.
• This partnership mirrors modern integrative and injury care clinics, where MD medical direction complements chiropractic and rehab services to improve safety and outcomes.

Section 2: The Core Physiology of Erection

The erection mechanism is a coordinated vascular-neural-hormonal event:

• Sexual arousal activates parasympathetic pathways (S2–S4), releasing nitric oxide (NO) via neuronal nitric oxide synthase (nNOS). Endothelial cells contribute NO via eNOS.
• NO increases cyclic guanosine monophosphate (cGMP), relaxing smooth muscle in the corpora cavernosa, allowing arterial inflow and sinusoidal expansion.
• Veno-occlusive mechanisms compress subtunical venules, maintaining rigidity.
• Sympathetic activity and phosphodiesterase type 5 (PDE5) degrade cGMP, reversing the erection.

Why vascular health dominates outcomes

• Endothelial dysfunction impairs NO bioavailability.
• Atherosclerosis reduces cavernosal inflow.
• Risk factors—hypertension, diabetes, dyslipidemia, smoking—accelerate these changes.

Neural integrity

• Peripheral neuropathy (especially diabetic), pelvic nerve injury (prostatectomy, pelvic surgery), and lumbar-sacral radiculopathy can impair signaling.
• Autonomic imbalance—high sympathetic tone—can blunt arousal and cause premature detumescence.

Hormonal context

• Testosterone modulates libido and influences NO pathways and PDE5 responsiveness.
• Thyroid, cortisol, and estradiol balance also affect energy, mood, libido, and vascular tone.

Psychogenic influences

• Depression, anxiety, performance fear, and relationship stress elevate sympathetic drive and disrupt arousal.
• Sleep disorders (including sleep apnea) impair endocrine rhythms and endothelial function.

Medication and iatrogenic contributors

• Antihypertensives (certain beta-blockers, thiazides), SSRIs/SNRIs, antipsychotics, opioids, 5-alpha-reductase inhibitors, and others can induce or worsen ED.
• Pelvic surgery and radiation can damage nerves and vasculature.

Section 3: Why ED Demands Cardiovascular and Metabolic Screening

My rule: an ED visit is a cardiovascular health visit. We screen for:

• Blood pressure patterns, including masked and nocturnal hypertension
• Lipid phenotype, apolipoprotein B, lipoprotein(a), and insulin resistance markers
• A1c, fasting glucose, and oral glucose tolerance or CGM when indicated
• High-sensitivity C-reactive protein (hsCRP), fasting insulin, CMP, CBC
• Thyroid panel, morning total and free testosterone, sex hormone–binding globulin (SHBG), estradiol
• PSA in age-appropriate men prior to testosterone therapy
• Sleep apnea risk (STOP-Bang), depression and anxiety scales

Rationale

• ED correlates with heightened risk of coronary artery disease and cerebrovascular disease.
• Metabolic dysfunction and sleep apnea compromise endothelial health and testosterone levels.
• Addressing these improves sexual function and long-term outcomes.

Section 4: Conventional Pharmacotherapy—PDE5 Inhibitors and Tachyphylaxis

PDE5 inhibitors (sildenafil, tadalafil, vardenafil, avanafil) enhance cGMP by inhibiting PDE5, augmenting NO-mediated vasodilation.

What I tell patients

• These agents improve erection quality when sexual stimulation is present but do not create desire.
• They can cause headache, flushing, nasal congestion, dyspepsia, visual disturbances, back pain (tadalafil), and interaction risks (especially nitrates).
• Tachyphylaxis is real. Some men report diminishing effect and dose escalation over time.

Why tachyphylaxis happens

• Persistent endothelial dysfunction and vascular disease can outpace the drug’s ability to compensate.
• Psychological conditioning and inconsistent adherence patterns play roles.
• Hormonal deficits may blunt response; low testosterone is associated with reduced PDE5 efficacy.

Practical steps if PDE5 response wanes

• Reassess cardiovascular status and comorbidities.
• Optimize testosterone if deficient (with safety protocols).
• Consider regenerative strategies (shockwave, PRP) to improve tissue-level biology.
• Address sympathetic overdrive, pain, and stress.
• Review medications that impair sexual function and coordinate changes with prescribing physicians.

Section 5: Regenerative Options—Extracorporeal Shockwave Therapy for ED

What shockwave therapy does

• Low-intensity extracorporeal shockwave therapy (Li-ESWT) applies acoustic pulses to penile tissue and the perineum to induce mechanotransduction.
• It creates controlled microtrauma that upregulates angiogenic mediators (e.g., VEGF), nitric oxide synthase, and growth factors, promoting neovascularization, improved endothelial function, and nerve regeneration.

Why this matters physiologically

• Capillary density and endothelial health improve cavernosal inflow.
• Neuropeptide and nNOS/eNOS upregulation supports erection initiation and maintenance.
• Tissue remodeling may address the root causes rather than masking symptoms.

Clinical practicality

• Noninvasive, office-based or supervised home-use devices exist.
• Minimal discomfort, transient erythema or bruising possible.
• Appropriate for men who do not tolerate or respond to PDE5 inhibitors.

Integration with chiropractic and rehab

• I pair shockwave sessions with pelvic and lumbosacral mobility work, diaphragmatic breathing, and autonomic balancing to maximize perfusion gains.
• By reducing myofascial tension around the pelvis and improving spinal mechanics, we decrease sympathetic tone and encourage parasympathetic activation that supports erectile physiology.

Section 6: Regenerative Options—Platelet-Rich Plasma (PRP) for ED

How PRP helps

• Concentrated autologous platelets release growth factors (PDGF, VEGF, TGF-β, IGF-1, EGF) after activation, stimulating angiogenesis, fibroblast activity, smooth muscle repair, and nerve regeneration.
• In diabetics and post-prostatectomy models—cases with neuropathy and vascular compromise—PRP has shown encouraging signals for tissue recovery.

Protocol considerations

• We use sterile technique, centrifuge whole blood to concentrate platelets, and inject at specified cavernosal and perineural sites when indicated.
• Local anesthetic is used; expect brief soreness or bruising.
• Sessions may be combined with Li-ESWT for synergistic effects.

Why PRP and shockwave together

• Shockwave opens a regenerative window via mechanotransduction and angiogenic signaling.
• PRP supplies a biologically rich milieu to accelerate and sustain repair.
• Clinically, the combination often reduces reliance on PDE5 inhibitors and extends the durability of the response.

Section 7: Testosterone: When, Why, and How We Use It Safely

Clarifying the role of testosterone

• Low testosterone does not automatically cause ED, but it impairs libido, energy, mood, and endothelial function and reduces responsiveness to PDE5 therapy.
• Before we add peptides or escalate PDE5 dosing, we verify hormonal status.

Evaluation

• Two morning total testosterone levels, ideally on separate days, using a reliable assay.
• If obesity or insulin resistance is present, measure SHBG and calculate free testosterone.
• If total T is low, check LH/FSH: high LH suggests primary testicular failure; low/inappropriately normal LH suggests central hypogonadism.
• If low T with low LH, check prolactin to evaluate for hyperprolactinemia.
• Evaluate estradiol, especially with gynecomastia.
• Rule out confounding conditions and medications.

Thresholds and clinical judgment

• We treat patients, not numbers. Symptoms plus confirmed low levels guide therapy.
• Many societies consider total T below ~300 ng/dL as consistent with hypogonadism, but free T and symptoms inform decisions.

Treatment goals

• Restore function and relieve symptoms, not chase a number.
• Practical target ranges may be 450–600 ng/dL for many patients, with individualized adjustments.
• Monitor for symptom relief and adverse effects.

Safety and monitoring

• Baseline and follow-up: PSA for age-appropriate men, digital rectal exam as indicated, hematocrit/hemoglobin (watch for erythrocytosis), lipids, liver enzymes as appropriate.
• Avoid initiation within several months of acute coronary events; coordinate with cardiology.
• Screen and manage sleep apnea (testosterone can worsen OSA by relaxing upper airway musculature).
• Educate regarding acne, fluid retention, gynecomastia, LUTS, mood changes, and clot risk.

Fertility considerations

• Exogenous testosterone suppresses spermatogenesis.
• For men seeking fertility, we favor gonadotropin-based strategies or selective protocols that preserve sperm production.

Section 8: Peptide Therapies—Where They Fit and How We Use Them Thoughtfully

Adjunctive peptides we may consider, case-by-case, with informed consent, quality sourcing, and medical oversight by Dr. Cardenas:

• Human chorionic gonadotropin (hCG)
  • Mechanism: LH mimic; stimulates Leydig cells to produce endogenous testosterone.
  • Use: Hypogonadism with fertility preservation; adjunct to TRT to maintain intratesticular testosterone.
  • Watch for: Estradiol elevation, water retention, mood shifts.
• Gonadorelin
  • Mechanism: GnRH analog; stimulates pituitary LH and FSH.
  • Use: Support endogenous testosterone and spermatogenesis.
  • Notes: Requires individualized dosing and monitoring.
• CJC-1295/Ipamorelin
  • Mechanism: GHRH analog plus ghrelin receptor agonist; enhances pulsatile growth hormone release.
  • Potential benefits: Sleep quality, body composition, recovery; indirect support of sexual vitality via metabolic and recovery gains.
  • Caution: Avoid high doses that impair insulin sensitivity; monitor glucose metrics.
• PT-141 (Bremelanotide)
  • Mechanism: Central melanocortin receptor agonist; acts independently of the NO pathway.
  • Benefits: Increases libido, may improve erectile function even when the NO pathway is compromised.
  • Side effects: Nausea is common; we start low and titrate carefully.
• BPC-157 and TB-500 (Thymosin Beta-4)
  • Mechanisms: Tissue repair, angiogenesis modulation, NO signaling support (BPC-157); cytoskeletal organization and healing support (TB-500).
  • Use: Adjuncts in musculoskeletal healing and potentially in pelvic tissue recovery.
  • Approach: Consider broader rehabilitation plans with attention to sourcing and patient selection.

Integration principles

• We assess hormones first; peptides are not a substitute for diagnosing and correcting hypogonadism, thyroid dysfunction, or uncontrolled cardiometabolic disease.
• We monitor responses and side effects and coordinate changes with Dr. Cardenas to ensure safety.

Section 9: How Integrative Chiropractic Care Supports ED Recovery

My role in ED care extends beyond adjustments. I focus on these goals:

• Reduce sympathetic overdrive and enhance parasympathetic activity to support NO-mediated vasodilation.
• Improve lumbosacral mechanics, pelvic alignment, and rib-diaphragm mobility to optimize perfusion and reduce pain.
• Release myofascial restrictions in the pelvic floor and hips that can impair vascular and neural function.
• Rebuild functional capacity through graded movement and stability training that supports vascular health and insulin sensitivity.

Techniques I commonly use

• Gentle spinal manipulation of the lumbar spine and sacroiliac joints to normalize segmental motion and reduce nociceptive drive.
• Myofascial release targeting iliopsoas, obturator internus/externus, piriformis, adductors, and pelvic floor as appropriate to reduce tension that can compress neurovascular structures.
• Diaphragmatic breathing and rib mechanics training to lower sympathetic tone and improve venous return.
• Neurodynamic mobilization and positional release to address nerve irritability when radiculopathy or peripheral entrapment contributes to symptoms.
• Corrective exercise: hip hinge mastery, gluteal activation, adductor–abductor balance, and walking programs to enhance endothelial function.
• Stress physiology coaching: sleep hygiene, mindfulness-based strategies, and HRV-informed pacing.

Why this helps

• Pain and immobility raise sympathetic tone and reduce sexual arousal capacity.
• Improved mechanics and circulation lower the physiologic barrier to erection.
• Autonomic balance enhances arousal, while better fitness and body composition support hormonal and endothelial health.

Section 10: Functional Medicine Foundations for Men with ED

I implement foundational elements that support every therapy:

• Nutrition
  • Emphasis on Mediterranean-style or DASH-like dietary patterns rich in polyphenols (e.g., leafy greens, berries, olive oil, nuts) to improve endothelial function.
  • Nitrate-rich vegetables (beets, arugula) to support NO availability.
  • Adequate protein for body composition and recovery; minimize ultra-processed foods and excess added sugars to reduce insulin resistance.
• Movement
  • Aerobic training (150–300 minutes/week moderate or 75–150 vigorous) and resistance training (2–3 sessions/week) to enhance NO bioavailability, insulin sensitivity, and testosterone.
• Sleep
  • 7–9 hours with consistent schedule; evaluate and treat sleep apnea; limit late caffeine and alcohol.
• Stress and mental health
  • Cognitive behavioral strategies, couples communication, and referral for psychotherapy when indicated to address anxiety, depression, or relationship stress.
• Weight management
  • Even modest weight loss (5–10%) improves erectile function, testosterone, and glycemic control.

Section 11: Drug-Induced ED—Spotting and Solving the Hidden Cause

We review medications meticulously:

• Antihypertensives: older nonselective beta-blockers and thiazides may impair erectile function. We coordinate with prescribing clinicians to consider alternatives with a more favorable sexual side-effect profile.
• SSRIs/SNRIs and antipsychotics: discuss options such as dose adjustments, switching agents, or adjunctive strategies when appropriate.
• Opioids and sedatives: counsel on dependence risks and sexual dysfunction; explore multimodal pain management.
• 5-alpha-reductase inhibitors: monitor sexual side effects and discuss risk-benefit.

Section 12: Post-Prostatectomy and Post-Radiation ED—Who Is a Candidate for Regeneration?

Patients who have completed curative intent therapy for prostate cancer often ask whether they can receive shockwave, PRP, hormone optimization, or peptide support.

Our approach

• With Dr. Cardenas, we confirm completion of cancer treatment and assess the disease-free interval.
• We review evolving guidance and scientific literature on safe timing for intervention.
• We consider Li-ESWT and PRP after appropriate clearance, especially when nerve-sparing surgery still leaves neurovascular compromise.
• We re-evaluate testosterone cautiously in eligible patients after a defined interval and in coordination with urology and oncology.

Why we proceed carefully

• We respect oncologic safety first and coordinate with the treating specialists.
• Our goal is to restore function while honoring the risk profile unique to these patients.

Section 13: Practical Tools—Questionnaires and Structured Intake

Because many men hesitate to speak openly, structured questionnaires help us open the conversation:

• Key screening questions
  • Do you have decreased libido?
  • Are your erections less strong than before?
• Additional tools
  • Sexual Health Inventory for Men (SHIM)
  • Androgen Deficiency in the Aging Male (ADAM) questionnaire

How we use them

• We place validated questionnaires in our intake process to normalize the discussion.
• Positive screens prompt respectful, focused exploration and comprehensive medical evaluation with Dr. Cardenas.

Section 14: The Stepwise, Multidisciplinary Plan We Use in Our Clinic

I structure care in phases:

1: Assess and secure safety

• • Immediate cardiometabolic and medication review; address red flags.
  • Baseline labs: CBC, CMP, A1c, fasting insulin/glucose, lipids (including apoB, Lp(a) when indicated), hsCRP, thyroid panel, total and free T, SHBG, estradiol, LH/FSH, prolactin, PSA as appropriate.
  • Sleep apnea screening and referrals.
  • Initiate foundational lifestyle interventions.
  • If appropriate, start or optimize PDE5 therapy; educate on timing and expectations.

2: Restore physiology</span>

• • • Integrative chiropractic care: spinal and pelvic alignment, myofascial release, autonomic regulation practices.
    • Movement and rehab: graded aerobic and resistance training; pelvic floor coordination for selected cases.
    • Consider Li-ESWT for vasculogenic ED; schedule a series of sessions.
    • Evaluate candidacy for PRP; discuss benefits, risks, and logistics.

3: Optimize hormones when indicated

• • • • If symptomatic hypogonadism is confirmed, co-manage TRT with Dr. Cardenas, ensuring sleep apnea and cardiovascular status are addressed.
      • For fertility goals, consider hCG or gonadorelin; avoid suppressive exogenous testosterone unless necessary and informed.
      • Monitor hematocrit, PSA, lipids, and clinical response at defined intervals.

4: Adjunct peptide strategies

• =”list-style-type: none;”>
  • • • • Consider bremelanotide (PT-141) for libido and erectile function; titrate cautiously to minimize nausea.
        • Consider CJC-1295/Ipamorelin for recovery and body composition in appropriate patients.
        • Consider BPC-157 and TB-500 as part of broader musculoskeletal recovery when indicated.

5: Review, refine, and sustain

• • • • • • Reassess SHIM and other patient-reported outcomes.
          • Adjust therapies based on objective markers and subjective improvement.
          • Continue integrative care emphasizing long-term vascular and metabolic health.

Section 15: Monitoring, Risks, and When to Pause

We proactively monitor:

• • • • • • Hematocrit/hemoglobin during TRT; pause or reduce dose if erythrocytosis occurs.
          • PSA per guidelines; refer for urologic evaluation if concerning changes arise.
          • Blood pressure, lipids, insulin resistance markers, and weight trajectory.
          • Sleep quality and apnea management adherence.
          • Mental health and relationship dynamics, referring to counseling when needed.

When to pause or defer therapy

• • • • • • Recent acute coronary events without cardiology clearance.
          • Active malignancy not yet adequately treated or monitored.
          • Uncontrolled severe hypertension or diabetes until stabilized.
          • Severe untreated sleep apnea when considering TRT.

Section 16: Chiropractic-Neurometabolic Integration—Why It Works Together

From my clinical observations over years of practice, improvements in spinal and pelvic function often translate into better autonomic balance. Men with chronic back or hip pain tend to live in sympathetic overdrive—tight, guarded, and exhausted. After restoring lumbar and sacroiliac mobility, releasing pelvic floor and hip musculature, and retraining diaphragmatic breathing, I see shifts in HRV, blood pressure variability, and subjective calm. These physiologic changes create a more favorable neurovascular environment for erections. Pairing this with shockwave or PRP can be especially effective because we align neural, vascular, and biomechanical factors at the same time.

Section 17: Personal Injury, Pain, and ED—The Overlooked Link

As a clinic that also manages personal injury cases, we often see men whose back or pelvic injuries coincide with ED. Mechanisms include:

• • • • • • Lumbar disc injury affecting lumbosacral nerve roots that contribute to pelvic function.
          • Pelvic fractures or soft-tissue trauma causing scarring and vascular impairment.
          • Chronic pain leading to opioid use and psychogenic stressors, compounding ED.

Our strategy blends:

• • • • • • Precise chiropractic and rehabilitative care to restore lumbopelvic dynamics.
          • Coordination with medical pain management to reduce opioids and switch to multimodal analgesia.
          • Regenerative therapies to encourage tissue healing.
          • Psychological support as needed.

Section 18: Real-World Expectations and Patient Communication

I set clear expectations:

• • • • • • Improvement in erectile function often occurs over weeks to months as we improve vascular and neural health.
          • PDE5 inhibitors can be a bridge, not always the destination.
          • Weight loss, sleep optimization, and consistent exercise materially improve outcomes.
          • Hormone optimization enhances response but is not a panacea; safety comes first.
          • Regenerative therapies are promising; results vary by severity, comorbidities, and adherence.

Section 19: Clinical Pearls I Use Daily

• • • • • • ED equals a prompt to evaluate the heart. We never ignore this.
          • Free testosterone matters, especially in obesity, because low SHBG can mask low bioavailable T.
          • If PDE5 efficacy drops, think endothelial repair: shockwave, PRP, nutrition, exercise, and stress modulation.
          • Treat sleep apnea before ramping up testosterone.
          • For post-prostatectomy patients, coordinate timing and strategy with urology and oncology.
          • Small wins—better sleep, improved back mobility, reduced stress—compound into better sexual health.

Section 20: Team Spotlight—How We Collaborate at Injury Medical Clinic PA

• • • • • • Dr. Maria Guadalupe Cardenas, MD, Internal Medicine
            • Medical Director and Collaborative Physician
            • Oversees diagnostics, risk stratification, and pharmacotherapy safety
            • Coordinates with cardiology, urology, and endocrinology as needed
          • Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST
            • Integrative chiropractic, functional medicine, rehabilitation programs, and regenerative therapy coordination
            • Focuses on pain resolution, autonomic balance, and movement restoration

Together we:

• • • • • • Build a single, patient-centered care plan.
          • Share data and track outcomes like SHIM scores, HRV, blood pressure, A1c, lipid risk, and body composition.
          • Adjust therapies based on evidence, patient preference, and safety.

Section 21: Putting It All Together—A Patient Journey

A typical journey might look like this:

• • • • • • Week 0–2: Intake, labs, cardiometabolic screen, sleep apnea assessment, start nutrition and movement plan, begin chiropractic and breathwork, trial PDE5 if appropriate.
          • Week 3–6: Series of Li-ESWT sessions; consider PRP consult; continue rehab and stress modulation. Review labs; if hypogonadism confirmed with symptoms, plan hormone strategy with Dr. Cardenas.
          • Week 6–12: Implement hormone optimization when indicated; consider peptides for libido or recovery; advance strength and aerobic prescription.
          • Month 3–6: Reassess outcomes; taper PDE5 dose if possible; maintain lifestyle upgrades; adjust therapies for durability.
          • Month 6–12: Long-term maintenance with periodic monitoring; refine goals and preserve gains.

Section 22: Final Thoughts—A Modern, Compassionate Approach to Men’s Sexual Health

ED is not just about the mechanics of erection—it is about the health of your arteries, nerves, hormones, relationships, and daily habits. Our multidisciplinary model in El Paso is designed to treat the person, not just the symptom. With medical direction from Dr. Cardenas and integrative care from our team, we combine safety with innovation—conventional medicines when needed, regenerative tools to rebuild tissue health, and chiropractic and rehab to restore function and calm the nervous system. This is how we help men move from frustration to confidence, from risk to resilience.

---

References

• • • • • • American Urological Association guideline on the management of erectile dysfunction

          • British Society for Sexual Medicine standards for the management of erectile dysfunction and testosterone deficiency
          • European Association of Urology guideline on sexual and reproductive health
          • Endocrine Society clinical practice guideline on testosterone therapy in men with hypogonadism
          • Practical guide to cardiovascular assessment in men with erectile dysfunction
          • Consensus recommendations on low-intensity shockwave therapy for erectile dysfunction
          • Platelet-rich plasma in erectile dysfunction: mechanisms and clinical outcomes
          • PDE5 inhibitors in erectile dysfunction: efficacy and safety
          • Obstructive sleep apnea, testosterone, and sexual function
          • Medication-induced sexual dysfunction: recognition and management
          • Autonomic nervous system and sexual function: implications for integrative care
          • Lifestyle interventions and endothelial health in ED
          • Diabetes-related neuropathy and erectile dysfunction

          • Post-prostatectomy erectile dysfunction: rehabilitation and regeneration